Optimizing choice of oral interferon-free treatment for genotype 1 hepatitis C virus using testing for NS5A resistance: a cost-utility analysis from the perspective of the Italian National Health Service

BACKGROUND: Patients with genotype-1 hepatitis C virus infection who have failed to respond to standard therapy or who relapse following treatment may be considered for an interferon-free regimen incorporating a nonstructural protein 5A (NS5A) inhibitor. Sustained virologic response (SVR) with these...

Descripción completa

Detalles Bibliográficos
Autores principales: Westerhout, Kirsten Y, Bouwmeester, Walter, Duchesne, Inge, Pisini, Marta, Piena, Marjanne A, Damele, Francesco, Gueron, Beatrice, Treur, Maarten, Belsey, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338846/
https://www.ncbi.nlm.nih.gov/pubmed/28280374
http://dx.doi.org/10.2147/CEOR.S117650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338846/
https://www.ncbi.nlm.nih.gov/pubmed/28280374
http://dx.doi.org/10.2147/CEOR.S117650

Ejemplares similares